STAT3 and breast carcinoma: In addition, the Src/Stat3 signaling pathway plays a crucial role in controlling JAB1 transcription in breast cancer cells, and treatment with Stat3 and Src-targeting siRNAs noticeably reduces JAB1 promoter function and expression [12].